Search results
Results from the WOW.Com Content Network
Its stock is a tracking stock of Applera, along with the tracking stock of Applera's larger Applied Biosystems Group business unit. Celera sequenced the human genome at a fraction of the cost of the publicly funded Human Genome Project (HGP), using about $300 million of private funding versus approximately $3 billion of taxpayer dollars.
The Applied Biosystems group had earlier already been renamed PE Biosystems, and it retained that name in the first incarnation of its tracking stock. In 2000, the Applied Biosystems name was restored to the group, with the new stock ticker symbol ABI, and PE Corporation became Applera, a combination of its two components' names, Appl (iedCel) era.
On May 6, 1999, the recapitalization of the company resulted in issuance of the two new classes of common stock, called PE Corporation-PE Biosystems Group Common Stock and PE Corporation-Celera Genomics Group Common Stock. [19] On that date, trading began in both new stocks on the New York Stock Exchange, to great excitement. [18]
A close look at Calvasina's work shows why economic growth meeting or exceeding positive expectations could be crucial to the stock market rally. Dating back to 1947, annual GDP has grown between ...
Listen and subscribe to Stocks in Translation on Apple Podcasts, Spotify, or wherever you find your favorite podcasts.. 2024 was a year of financial surprises for many investors. The S&P 500 index ...
The spotlight remained on Nvidia, whose chips are powering much of the move into AI and whose stock has become a symbol of the surrounding frenzy. It rose 8.8% after plunging nearly 17% the day ...
A ticker symbol or stock symbol is an abbreviation used to uniquely identify publicly traded shares of a particular stock or security on a particular stock exchange. Ticker symbols are arrangements of symbols or characters (generally Latin letters or digits) which provide a shorthand for investors to refer to, purchase, and research securities.
Venter (and Smith)'s previous company, Celera Genomics, was a driving force in the race to sequence the human genome. [9] The firm takes its name from the phrase synthetic genomics which is a scientific discipline of synthetic biology related to the generation of organisms artificially using genetic material.